| # | Drug | Count |
|---|---|---|
| 0 | BUPRENORPHINE | 60 |
| 1 | ETANERCEPT | 36 |
| 2 | TREPROSTINIL | 28 |
| 3 | GLATIRAMER ACETATE | 23 |
| 4 | ADALIMUMAB | 22 |
| 5 | FUROSEMIDE | 19 |
| 6 | BOSENTAN | 16 |
| 7 | INTERFERON BETA-1A | 16 |
| 8 | METFORMIN | 16 |
| 9 | METFORMIN ER 500 MG | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGVISOMANT | 11 | 0.0027 |
| 1 | RILONACEPT | 2 | 0.0017 |
| 2 | CAPLACIZUMAB | 2 | 0.0011 |
| 3 | HYALURONIC ACID | 1 | 0.0009 |
| 4 | INTERFERON BETA-1B | 14 | 0.0007 |
| 5 | TRIMETHOBENZAMIDE HYDROCHLORIDE | 1 | 0.0007 |
| 6 | BUPRENORPHINE | 60 | 0.0006 |
| 7 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 8 | SENNOSIDES A AND B | 1 | 0.0006 |
| 9 | TAMSULOSIN HYDROCHLORIDE | 12 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Partial Opioid Agonist [EPC] | 60 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 36 |
| 2 | Prostacycline Vasodilator [EPC] | 28 |
| 3 | Loop Diuretic [EPC] | 20 |
| 4 | Endothelin Receptor Antagonist [EPC] | 18 |
| 5 | Interferon beta [EPC] | 16 |
| 6 | Insulin Analog [EPC] | 13 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 8 | GLP-1 Receptor Agonist [EPC] | 12 |
| 9 | Interleukin-4 Receptor alpha Antagonist [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Partial Opioid Agonist [EPC] | 60 | 0.0006 |
| 1 | Prostacycline Vasodilator [EPC] | 28 | 0.0002 |
| 2 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 3 | Soluble Guanylate Cyclase Stimulator [EPC] | 6 | 0.0002 |
| 4 | Vasopressin V2 Receptor Antagonist [EPC] | 2 | 0.0001 |
| 5 | Phenylalanine Metabolizing Enzyme [EPC] | 1 | 0.0001 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 3 | 0.0001 |
| 7 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 8 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 9 | Endothelin Receptor Antagonist [EPC] | 18 | 0.0001 |